• Article

    SER-109, an Oral Microbiome Therapy for rCDI

    April 3, 2023

    Dr. Arobelidze Clinical question: In patients with recurrent Clostridioides difficile infection (rCDI), is the use of oral microbiome therapy associated with reduced risk of recurrence of the...